TP53 and brain neoplasm: In the present study, we conducted a time course analysis of the expression of molecules along the p53 pathway after the treatment of malignant brain tumor cells with CEP-1347, which revealed a marked increase in MDM2 expression, particularly in its protein levels, induced by CEP-1347.